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Different routes of endotoxin administration have 
been used to mimic inflammatory and metabolic re­
sponses observed during sepsis. Because the origin of 
endotoxemia may affect the reactions to endotoxin, we 
compared the induction of tumor necrosis factor 
(TNF), interleukin-6 (IL-6), hormones, and glucose pro­
duction after endotoxin (1.0 /xg/kg Escherichia coli 
0111:B4) administration into a peripheral (n = 8) ver­
sus the portal (n — 8) vein in anesthetized dogs. Prior 
to endotoxin, a laparotomy was performed for cannu- 
lation of hepatic vessels. To evaluate the effects of sur­
gery and anesthesia, we also studied the effects of pe­
ripheral endotoxin administration in six awake dogs. 
The rate of appearance of glucose was measured by 
primed continuous infusion of [6,6-2H2]glucose. In an­
esthetized dogs, arterial concentrations of TNF and IL-
6 increased after endotoxin administration (P < 0.01 
vs basal; NS between groups). Net hepatic TNF produc­
tion was increased after endotoxin administration (pe­
ripheral vs portal endotoxin administration: 533 ± 177 
vs 2135 ± 1127 ng/min, both P < 0.05 vs basal; NS be­
tween groups). Net hepatic IL-6 production was stimu­
lated only after portal endotoxin delivery (from 86 ± 
129 to 4740 ± 1899 ng/min, P  < 0.05; NS between 
groups). Although there were no differences in neuro­
endocrine activation, portal endotoxin administration 
resulted in decreased glucose production compared 
with peripheral administration (13.6 ± 0.9 vs 16.8 ±1.2  
^tmol/kg • min, P  < 0.05). In contrast to anesthetized 
dogs, endotoxin increased glucose production consid­
erably in awake dogs from 13.8 ± 1.2 to 24.2 ± 3.2 /mmol/ 
kg * min (P < 0.05; P < 0.05 vs anesthetized dogs). The 
contribution of anesthesia and surgery increased the 
endotoxin-induced IL-6 response by ~350% compared 
with the effect of endotoxin in awake dogs (P < 0.01). 
In conclusion, there are no major differences in the 
responses to endotoxin between peripherally treated 
and portally treated dogs, except for differences in glu­
cose production. Portal delivery compared with sys­
temic delivery of endotoxin alters hepatic metabolism  
through nonendocrine mechanisms, reflected in de­
creased glucose production. The inflammatory, endo­
crine, and metabolic effects of endotoxin are altered 
by the combination of surgery and anesthesia. © 1997
Academic Press
Key Words: cytokines; hormones; liver; glucose pro­
duction; stable isotopes; portal vein.
INTRODUCTION
Endotoxin is often used to mimic the inflammatory 
and metabolic responses during sepsis. In the litera­
ture various routes of administration have been used. 
In these experiments endotoxin was given intraperito- 
neally (rats), intravenously (dogs, rats, humans), or 
into the portal vein (dogs, swine) [1-10]. Endotoxin is 
readily cleared from the circulation by macrophages 
with concomitant macrophage activation, resulting in 
the release of inflammatory mediators, including tumor 
necrosis factor (TNF) and interleukin-6 (IL-6) [11]. As 
the liver contains a major proportion of the total body 
macrophage content, it is possible that endotoxin deliv­
ery by portal and systemic routes result in different 
cytokine responses. Concomitantly, this difference in 
cytokine response may lead to a difference in hepatic 
glucose metabolism.
The objective of this study was to compare the in­
flammatory, endocrine, and metabolic responses to ad­
ministration of a bolus of endotoxin into a peripheral 
versus the portal vein in anesthetized dogs. High-dose 
endotoxin causes hemodynamic instability and de­
creased organ perfusion [1, 6, 8, 10, 12], Because circu­
latory shock itself may induce metabolic changes, we 
injected that dose of endotoxin (1.0 ngfkg) that induces 
significant secretion of TNF and IL-6 in anesthetized 
dogs without the induction of circulatory shock [13]. To 
control for the effects of surgery and anesthesia, we 
also studied the effects of peripheral endotoxin admin­
istration in awake dogs.
MATERIALS AND METHODS
Animals
Twenty-two male mongrel dogs (weight: 28 ± 2 kg, mean ± SEM) 
were studied. Sixteen were studied under general anesthesia (portal
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endotoxin administration n = 8; peripheral administration, n — 8). 
Six awake dogs served as the control group. Prior to the study all 
dogs were observed for 2 weeks. Only dogs with normal stools, no 
febrile disease, and normal physical examination and laboratory re­
sults were included. The dogs were fed a standard diet once a day 
consisting of 64% carbohydrate, 1% fat, 26% protein, 3% fiber, based 
on dry weight (D. B. Brok, Hope Farms, Woerden, The Netherlands). 
The study was approved by the Ethical Committee for Animal Exper­
iments and performed according to the guidelines of the Dutch Law 
for Animal Experiments.
Operative Procedure
Awake dogs. To get used to the experimental procedure, these 
dogs were trained daily in the experiment room to lie quiet for a few 
hours. Four days before each experiment a femoral artery catheter 
was inserted during general anesthesia [1% isoflurane (Forene, Ab­
bott Laboratories, Queensbourough, Kent, United Kingdom) and 
N20 /0 2 (1:1) ventilation]. After insertion, the catheter was filled with 
heparin (200 U/ml), closed, and placed in a subcutaneous pocket.
Anesthetized dogs. After an overnight fast (18 h) the dogs were 
anesthetized, intubated, and ventilated artificially. General anesthe­
sia was induced by intramuscular injection of xylazine (0.15 ml/kg; 
Rompun, Bayer, Germany), ketamine hydrochloride (20 mg/kg; Ae- 
scoket, Aesculaap BV, The Netherlands), and atropine (0.05 mg/kg; 
Centrafarm Services BV, Etten-Leur, The Netherlands) and main­
tained by intravenous sufentanil (1,5 /jg/kg • h; Janssen-Cilag BV, 
Tilburg, The Netherlands), 1% isoflurane, and N20 /0 2 (1:1) ventila­
tion. A urine catheter and a rectal temperature probe were inserted. 
A Swan Ganz thermal dilution catheter was positioned in the pulmo­
nary artery through the external jugular vein. A femoral artery cath­
eter was inserted for blood sampling and continuous intraarterial 
blood pressure monitoring.
Subsequently, the abdominal cavity was opened through a midline 
incision. The gastroduodenal vein was ligated at its junction with 
the portal vein. Doppler flow probes (20-MHz pulsed Doppler mod­
ules, epoxy probe, obtained from G, J. Hartley, Baylor College of 
Medicine, Houston, TX) were positioned around the hepatic artery 
and the portal vein. Flexible Tygon catheters (S54-HL, Norton Com­
pany, Rubber BV, Hilversum, The Netherlands, ID 0.040-in. i.d.,
0.070-in. o.d., 15-in. length) were inserted into the portal and hepatic 
veins, located between the left medial and left lateral lobes of the 
liver. One catheter was advanced over 5 cm into the portal vein, with 
the tip distal to the portal vein Doppler flow probe. The other catheter 
was advanced anterogradely, over 2 cm, into the hepatic vein. The 
surgical preparation of the animal model lasted ~120 min. After 
surgery the catheters were flushed with saline and kept patent by 
a slow infusion of saline.
Experimental Design
Awake dogs. On the morning of the experiment, the skin around 
the pocket was anesthetized with lidocaine and opened. Subse­
quently, the femoral artery catheter was obtained from the pocket 
and attached to a monitor for continuous intraarterial blood pressure 
monitoring and blood sampling.
Anesthetized and awake dogs, Each study period started at 8.00 
AM after an overnight fast of 18 h. A catheter was inserted into 
the right cephalic vein for infusion of saline and administration of 
endotoxin. Another catheter was inserted into the left cephalic vein 
for [6,6-2H2]glucose infusion. After obtaining blood samples for deter­
mination of basal enrichment, a primed (17.6 ¿¿mole/kg), continuous 
(0.22 /¿mole/kg * min) infusion of filter-sterilized [6,6-2H2]glucose 
(99%; Isotec Inc., Miamisburg, OH) was started at t -  —120 min, 
using a calibrated syringe infusion pump. After 120 min of infusion 
of [6,6-2H2]glucose, four blood samples were taken at intervals of 5 
min for measurement of glucose enrichments. In addition blood was 
sampled for analysis of concentrations of hormones and cytokines. 
Subsequently, a bolus dose of 1.0 //g/kg Escherichia coli endotoxin 
was injected into either the right cephalic vein in awake (n = 6) and 
anesthetized (n ~ 8) dogs or into the portal vein in anesthetized dogs 
(n = 8).
Endotoxin derived from£. coli (0111:B4, Lot 31H4000, phenol ex­
tracted; Sigma Chemical Co., St. Louis, MO) was suspended in sterile 
pyrogen-free saline. A stock solution of 100 ¡xglml was made, divided 
into several plastic tubes (Costar, Cambridge, MA), and kept frozen 
at -20°C. Before use the endotoxin solution was thawed at 37°C, 
vortexed for 3 min, diluted, and vortexed again for 10 min.
In the awake dogs, mean arterial blood pressure and heart rate 
were monitored continuously and recorded every 15 min. In the anes­
thetized dogs, mean arterial blood pressure, heart rate, electrocardio­
gram, central venous pressure, pulmonary artery pressure, and pul­
monary artery wedge pressure were monitored continuously and re­
corded at intervals of 15 min. Cardiac output was determined by 
thermal dilution technique using a cardiac output computer (Ed­
wards Labs, Santa Ana, CA). Blood flow in the hepatic artery and 
portal vein was monitored continuously with Doppler flow probes, 
connected to a flowmeter (three-channel ultrasonic flow-dimension 
system; G. J. Hartley, Baylor College of Medicine) [141 and recorded 
every 10 min. Total hepatic blood flow was the sum of the blood flow 
through the hepatic artery and portal vein.
Blood samples for the determination of glucose enrichment and 
plasma concentrations of glucose, insulin, epinephrine, norepineph­
rine, glucagon, and cortisol were collected hourly from the femoral 
artery. Blood samples for the determination of plasma concentration 
of TNF and IL-6 were collected hourly and also 30 and 90 min after 
endotoxin administration from the femoral artery and (in anesthe­
tized dogs) from the portal vein and a hepatic vein.
The observation period after endotoxin administration lasted 240 
min. At the end of each experiment the correct position of the cathe­
ters was confirmed radiographically. Subsequently, the dogs were 
sacrificed by intravenous injection of sodium pentobarbital.
Sample Processing
Blood was collected in prechilled tubes and stored on ice. Immedi­
ately after sampling the blood samples were centrifuged (3000g, 4DC,
10 min) and plasma was stored at — 20°C until determination. Blood 
for analysis of insulin, cortisol, TNF, IL-6, and [6,6-2H2]glucose was 
collected in heparinized tubes. Whole blood was added to reduced 
glutathione-EGTA buffer and trasylol for the determination of cate­
cholamines and glucagon, respectively.
Biochemical Analysis
All measurements were performed in duplicate. All samples of 
each animal were analyzed in the same run. Plasma insulin concen­
tration was measured by radioimmunoassay (RIA) (Insulin RIA 100, 
Pharmacia Diagnostics AB, Uppsala, Sweden; detection limit, 2 mU/ 
liter), as was plasma glucagon (Daiichi Radioisotope Laboratories, 
Tokyo, Japan; detection limit, 15 ng/liter; glucagon antiserum elic­
ited in guinea pigs against pancreatic specific glucagon; cross-reactiv­
ity with glucagon-like substances of intestinal origin less than 1%). 
Plasma catecholamine concentrations were measured by HPLC and 
electrochemical detection, after purification on Biorex 70 and concen­
tration by solvent extraction [15], and cortisol by fluorescence polar­
ization immunoassay on Technical Device X (Abbott Laboratories, 
Chicago, IL; detection limit, was 50 nmol/liter).
TNF bioactivity in plasma was measured with a WEHI 164 sub­
clone 13 line (kindly provided by W.A. Buurman, Academic Hospital, 
Maastricht, The Netherlands). The WEHI assay is based on the cyto­
toxic action of TNF on this fibroblast cell line [16]. TNF standard 
contained recombinant human TNF (Ernst-Boehringer, Vienna, Aus­
tria), which was serially diluted [16]. The detection limit was 10 
pg/ml. IL-6 bioactivity was measured with an IL-6-dependent B-9 
hybridoma cell line (kindly provided by L. A. Aarden, Central Labora­
tory of the Netherlands Red Cross Blood Transfusion Service, Am­
sterdam, The Netherlands) [17]. The detection limit of the IL-6 assay 
was 1 pg/ml. IL-6 standard contained human recombinant IL-6 
(HECS; Costar, Badhoevedorp, The Netherlands), which was serially
diluted.
Glucose concentrations and enrichments were determined by gas 
chromatography-mass spectrometry (Gas Chromatograph Model 
5890 II, Mass Spectrometer Model 5989 A, Hewlett-Packard, Fuller-
MOENIRALAM ET AL.: PORTAL VERSUS SYSTEMIC E N D OTOXEMIA IN  DOGS 49
ton, CA; column Helifiex AT-1, 30 cm X 0.25 mm X 0.2 fjrn, Alltech, 
Deerfield, IL). /?-Phenyl-glucose was used as internal standard [181 
[intraassay coefficient of variation of 1 to 4%, interassay coefficient 
of variation 1.5 to 5%; detection limit, 1.5 mM (0.5% enriched)].
Statistical Analysis and Calculations
All values are expressed as means ± SEM. The data were analyzed 
by two-way (i.e., group and time) analysis of variance for repeated 
measurements and the Newman-Keuls test for post hoc testing. For 
comparison between the two sampling sites of cytokines within each 
group the Wilcoxon test for paired samples was used. A P  value <  
0.05 was considered to be statistically significant.
Systemic vascular resisitance (SVR) was calculated using the fol­
lowing formula [12]: SVR = [(MABP -  CVP) X 80]/C0, where MABP 
is mean arterial blood pressure (mm Hg), CVP is central venous 
pressure (mm Hg), and CO is cardiac output (liters/min). SVR is 
given as X 104 dyn • s cm-5. Net hepatic TNF and IL-6 production 
was calculated using the following formula: net hepatic cytokine pro­
duction = (Qhv X C h v )  ~  [ ( Q p v  ^ CPV) + ( Q u a  X Cj?a)]> where Q h v >  
QPV} and Qha are blood flow through the hepatic vein, portal vein, and 
hepatic artery, and Chv, CPV, and CpA are cytokine concentrations in 
the hepatic vein, portal vein and femoral artery, respectively. Net 
hepatic cytokine production is given in nanograms per minute. The 
non-steady-state equations were used to calculate the rate of appear­
ance (Ra) of glucose as adapted for the use of stable isotopes [19].
RESULTS
Temperature
Basal temperature was slightly higher in awake dogs 
(38.2 ± 0.1°C) versus anesthetized dogs (peripheral, 
36.2 ± 0.4°C; portal 35.9 ± 0.4°C;P < 0.05). Endotoxin
increased the temperature in the conscious dogs to a 
maximum 40.6 ± 0.5°C (P < 0.01), but did not affect 
the temperature in anesthetized dogs.
Hemodynamics
Endotoxin induced a hyperdynamic response in the 
circulation of anesthetized dogs (Fig. 1). Cardiac output 
increased transiently by 30—35% (P < 0.05 vs basal) 
in both groups to a peak value at 60 min after endotoxin 
administration. The route of endotoxin administration 
did not affect the hemodynamic responses to endotoxin. 
Systemic vascular resistance decreased after endotoxin 
to a nadir at 60 min (peripheral group from 0.39 ± 0.04 
to 0.27 ± 0.02 X 104 dyn*s cm-5; portal group from 
0.44 ± 0.04 to 0.29 ± 0.03 X 104 dyn • s cm“5; P < 0.05 
vs basal; NS between both groups). Total hepatic blood 
flow (basal: 9.0 ± 0.6 ml/kg*min vs 8.1 ± 0.4 ml/ 
kg • min, respectively) was not affected by portal or sys­
temic endotoxin administration. In awake dogs endo­
toxin resulted in a transient increase in blood pressure 
(P < 0.05 vs anesthetized dogs).
Cytokines
In anesthetized dogs peak arterial levels of TNF were 
reached 60 min after endotoxin administration, with a 
gradual decline to baseline afterward (portal group, 
from below detection limit to 5 ± 2 ng/ml, vs peripheral 
group, from below detection limit to 6 ± 2 ng/ml, both 
P < 0.01 vs basal) (Fig. 2). Arterial levels of TNF were
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FIG. 1. Hemodynamic parameters before and after administra­
tion of 1.0 jig/kg endotoxin into a cephalic vein (O) or into the portal 
vein (•)  in anesthetized dogs and into a cephalic vein in awake dogs 
(□). MABP, mean arterial blood pressure; HR, heart rate; CVP, cen­
tral venous pressure; PWP, wedge pressure; CO, cardiac output. 
Swan Ganz measurements were not obtained in control dogs. All 
values are given as means ± SEM. <  0.05 between awake and 
anesthetized dogs. There were no differences between both anesthe­
tized groups. Cardiac output was significantly increased 60-90 min 
after endotoxin administration in both anesthetized groups (P < 
0.05). MABP was significantly higher in awake dogs compared with 
anesthetized dogs.
There was no net hepatic TNF production prior to endo­
toxin administration. However, net hepatic TNF pro­
duction increased significantly after endotoxin admin­
istration in both groups (NS between groups) (Table 
1). Data on plasma TNF levels were not obtained in 
not affected by the route of endotoxin administration, the conscious dogs, because these plasma samples were
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FIG. 2. Plasma TNF levels (ng/ml) in the femoral artery (circles) 
and hepatic vein (triangles) before and after administration of 1.0 
¿¿g/kg endotoxin into a cephalic vein or into the portal vein, All values 
are given as means ± SEM. There was no difference between the 
groups. Plasma TNF levels were increased in both groups (P <  0.01 
vs basal). Plasma TNF levels were higher in the hepatic veins than 
in the femoral artery after portal endotoxin administration but not 
after peripheral endotoxin administration.
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FIG. 3. Plasma IL-6 levels (ng/ml) in the femoral artery (circles) 
and hepatic vein (triangles) before and after administration of 1.0 
fxg/kg endotoxin into a cephalic vein or into the portal vein. All values 
are given as means ± SEM. There was no difference between the 
groups. Plasma IL-6 levels were increased in both groups CP < 0.01 
vs basal). Plasma IL-6 levels were higher in the hepatic veins than 
in the femoral artery after portal endotoxin administration (AUC: P 
< 0,05), but not after peripheral endotoxin administration.
thawed by accident and therefore we could not obtain 
reliable plasma TNF levels.
Endotoxin administration increased arterial plasma 
IL-6 concentrations in all dogs, with peak levels 180 
min after endotoxin administration (portal group, from
2 ± l t o 9 5  ± 14 ng/ml, vs peripheral group, from 2 ±
1 to 86 ± 15 ng/ml, both P < 0.01 vs basal) (Fig. 3). 
The route of administration did not influence the arte­
rial IL-6 concentrations in the anesthetized dogs, but 
the values were about three times higher in the anes­
thetized dogs compared with the awake dogs (awake
TABLE 1
Net Hepatic TNF and IL-6 Balance (ng/min) before and after Administration of 1.0 fJLglkg Endotoxin
into a Cephalic (C) or the Portal (P) Vein in Anesthetized Dogsa
Time (min)
0 30 60 90 120 180 240
TNF
C 3 ± 77 533 ± 177* 216 ± 154 -395 ± 323 202 ± 95 180 ± 145 97 ± 151
P 7 ± 11 416 ± 274 2135 ± 1127* -3 6  ± 374 82 ± 40 147 ± 128 152 ± 171
IL-6
C 319 ± 194 311 ± 421 1403 ± 921 2419 ± 1384 950 ± 2838 -2060 ± 3294 -1573 ± 2313
P 86 ± 129 -262  ± 427 927 ± 1195 4740 ± 1899* 587 ± 1220 2622 ± 2973 -3100 ± 2376
a Values are given as means ± SEM.
*P  < 0.05 vs basal values. There were no significant differences between groups.
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dogs, from below detection limit to 27 ± 3 ng/ml, P < 
0.01 vs basal; P < 0.05 vs both anesthetized groups). 
There was no net hepatic IL-6 production prior to endo­
toxin administration. Net hepatic IL-6 production was 
stimulated after portal, but not after peripheral, endo­
toxin administration (P <  0,05 vs basal)(ns between 
groups) (Table 1).
Glucoregulatory Hormones
Plasma concentrations of glucoregulatory hormones 
are shown in Fig. 4. The route of endotoxin did not
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FIG. 5. Arterial plasma levels (mmol/liter) and rate of appear­
ance (i2„) of glucose (¿¿mol/kg * min) before and after bolus injection 
of endotoxin (1,0 /¿g/kg) into a cephalic (O) and the portal (•) vein 
in anesthetized dogs and into a cephalic vein in awake dogs (□), 
Values are given as means ± SEM. *P <  0.05 between awake and 
anesthetized dogs, < 0.05 between both anesthetized groups, *+P 
= 0.06 between both anesthetized groups.
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PIG. 4. Arterial plasma concentrations of insulin (mU/liter), glu­
cagon (ng/liter), epinephrine (pmol/liter), norepinephrine (pmol/liter) 
and cortisol (¿¿mol/liter) after endotoxin injection (1.0 //g/kg) into a 
cephalic (O) or the portal (•) vein in anesthetized dogs and into a 
cephalic vein in awake dogs (□). Values are given as means ± SEM. 
There were no differences between both anesthetized groups. *P <  
0.05 between awake and anesthetized dogs.
affect the neuroendocrine response to endotoxin in the 
anesthetized dogs.
Prior to injection of endotoxin, concentrations of cor­
tisol and glucagon were higher in anesthetized dogs, 
whereas insulin and norepinephrine levels were lower 
compared with awake dogs (P < 0.05). Endotoxin stim­
ulated insulin secretion only in awake dogs (P <  0.05), 
whereas glucagon secretion was increased in all three 
groups (NS between groups). There was a variable re­
sponse of (nor)epinephrine to endotoxin within each 
group (NS between groups). Cortisol concentrations did 
not change after endotoxin in anesthetized dogs, 
whereas cortisol increased to higher values within 3 h 
of endotoxin in awake dogs compared with anesthe­
tized dogs (P < 0.01).
Glucose Kinetics
Plasma concentrations and rates of appearance of 
glucose are shown in Fig. 5. Basal plasma glucose 
concentrations were not different between the three 
groups. Basal rate of appearance of glucose was not 
different in the three groups (conscious dogs: 13.8 ± 
1.2 //mole/kg* min; anesthetized dogs: peripheral 
group, 16.5 ± 1.3 /imole/kg * min, and portal group, 15,8 
± 1.1 ^mole/kg * min). In anesthetized dogs, peripheral 
injection of endotoxin did not influence glucose (16.8 
± 1.2 //mole/kg ■ min at 240 min), whereas a significant 
decrease was found after intraportal injection (13.6 ± 
0.9 /¿mole/kg ■ min at 240 min; P <  0,05 vs peripheral 
endotoxin administration). In contrast, endotoxin in­
duced a considerable rise of —75% in glucose produc-
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tion in the awake dogs (P  <  0.05 vs basal; P  < 0.05 vs 
anesthetized dogs).
DISCUSSION
This study indicates that the inflammatory and met­
abolic effects of endotoxin are in part dependent on 
the route of endotoxin delivery. Although intraportal 
injection of endotoxin stimulated hepatic TNF and IL- 
6 production, and peripheral injection of endotoxin 
stimulated only hepatic TNF but not hepatic IL-6 pro­
duction, there were no differences in cytokine re­
sponses between both groups. Nonetheless, hepatic glu­
cose production decreased after portal endotoxin ad­
ministration but not after peripheral delivery of 
endotoxin. The combination of surgery and anesthesia 
increased the IL-6 response and modulated the neuro­
endocrine response to endotoxin, associated with the 
absence of the normal stimulation of hepatic glucose 
production to endotoxin. Therefore, the effects of endo­
toxin, at least with respect to glucose production, are 
dependent on the site of entry into the circulation. 
Moreover, the effects of endotoxin are altered by the 
combination of surgery and anesthetic agents.
TNF and IL-6 levels were considerably increased 
after endotoxin administration. In accordance with the 
literature, the increase in plasma IL-6 levels was pre­
ceded by a rise in plasma TNF levels [7,13]. There were 
no differences in plasma cytokine levels in relation to 
the origin of endotoxin. However, in accordance with 
previous observations, there was a large variability in 
cytokine responses to endotoxin within each group [20]. 
We cannot exclude the possibility that the detection of 
differences in cytokine production between both anes­
thetized groups is precluded by this large within-group 
variability.
The effects of the route of endotoxin administration 
were studied in anesthetized dogs. In these dogs a lapa­
rotomy was performed on the day of the study for can- 
nulation of the hepatic vessels. Therefore, the inflam­
matory, neuroendocrine, and metabolic effects in these 
dogs were affected by the combination of surgery, anes­
thesia, and endotoxin. However, this combination of 
factors does not invalidate our conclusions with respect 
to portal versus peripheral delivery of endotoxin, be­
cause the circumstances were identical for both groups 
of anesthetized dogs except for the route of endotoxin 
administration.
Hepatic glucose production was stimulated consider­
ably by peripheral endotoxin administration in awake 
dogs, in contrast to anesthetized, operated dogs. The 
metabolic changes induced by endotoxin are thought 
to be mediated at least in part by the induction of TNF 
and IL-6. Administration of IL-6 and TNF increases 
glucose production in dogs and humans in association 
with neuroendocrine activation [21—25]. However, de­
spite the considerable response of TNF and IL-6, the 
stimulatory effects of endotoxin on hepatic glucose pro­
duction were absent in anesthetized dogs. There were 
differences in endotoxin-induced neuroendocrine acti­
vation between awake and anesthetized dogs. Although 
insulin and norepinephrine levels were higher in 
awake dogs, cortisol and glucagon concentrations were 
higher in anesthetized dogs. Therefore, we cannot ex­
clude the possibility that the discrepancy in the effects 
of endotoxin on glucose production between awake and 
anesthetized dogs are related to these differences in 
neuroendocrine activation.
Portal administration of endotoxin decreased hepatic 
glucose production in anesthetized dogs. This effect 
was not caused by differences in secretion of glucoregu- 
latory hormones, because there were no endocrine dif­
ferences between both groups of anesthetized dogs. It 
has been suggested that the hepatic response to endo­
toxin involves the release of inflammatory mediators, 
like cytokines from Kupffer cells which interact with 
hepatocytes to induce nitricoxide production [26]. Re­
cent studies have provided evidence that nitric oxide 
may be an inhibitory mediator of the effects of endo­
toxin on hepatic glucose production [27, 28]. Endotoxin 
exposure and clearance are higher after portal then 
after peripheral endotoxin delivery [4]. It is possible 
that in our study the degree of hepatic endotoxin expo­
sure, which is higher after portal then after peripheral 
endotoxin delivery, altered glucose production by intra- 
hepatic mechanisms like nitric oxide rather than by 
endocrine mechanisms. Hasibeder et al. studied the ef­
fects of systemic versus mesenteric artery infusion of 
endotoxin in circulatory stable pigs [29], Interestingly, 
they found that mucosal mirovascular dysfunction is 
dependent largely on the local microvascular endotoxin 
concentration, supporting the hypothesis that local 
mechanisms are important in the reaction to endotoxin.
In summary, there are no major differences in the 
responses to endotoxin between peripherally treated 
and portally treated dogs, except for minor differences 
in glucose production. The glucoregulatory response to 
endotoxin is altered by the site of entry of endotoxin 
into the circulation, probably through nonendocrine 
mechanisms. The inflammatory, neuroendocrine, and 
metabolic effects of endotoxin are altered by the combi­
nation of surgery and anesthesia.
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